Jeremy Paull

Company: Starpharma
Job title: Vice President, Development and Regulatory Affairs
Seminars:
Branching Out: DEP® Dendrimer Nanoparticles as a Versatile Platform for Precision Cancer Radiotheranostics 1:45 pm
• Starpharma’s polylysine DEP® dendrimers for development of radiotheranostic pairs • Utility of DEP® platform for targeted delivery of radiotheranostics • Overview of DEP® HER2-targeted radiotheranosticsRead more
day: Day 1 - Track A (PM)